Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: The Atherosclerosis Risk in Communities (ARIC) study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 11, 2009, Pages 1194-1201

  Alonso, A ^a   Mosley Jr , T H ^b   Gottesman, R F ^c   Catellier, D ^d   Sharrett, A R ^e   Coresh, J ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d IL   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; ETHNICITY; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

AFRICAN AMERICANS; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; DEMENTIA; DIABETES COMPLICATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 72249102169     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.176818     Document Type: Article

References (43)

1. Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the Aging, Demographics, and Memory Study. Neuroepidemiology 2007;29:125-132
2. Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004;52:195-204. (Pubitemid 38233480)
3. Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-1122
4. Borenstein Graves A. Alzheimer's disease and vascular dementia. In: Nelson LM, Tanner CM, Van Den Eeden SK, et al., eds Neuroepidemiology: from principles to practice. New York: Oxford University Press, 2004:102-130
5. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-175
6. Launer LJ. Demonstrating the case that Alzheimer's disease is a vascular disease: epidemiologic evidence. Ageing Res Rev 2002;1:61-77. (Pubitemid 38340352)
7. Bailey TL, Rivara CB, Rocher AB, et al. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 2004;26:573-578 (Pubitemid 38879242)
8. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000;21:49-55. (Pubitemid 30224785)
9. Hayden KM, Zandi PP, Lyketsos CG, et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County Study. Alzheimer Dis Assoc Disord 2006;20:93-100. (Pubitemid 44305908)
10. Luchsinger JA, Tang MX, Stern Y, et al. Diabetes mellitus and Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001;154:635-641 (Pubitemid 32888781)
11. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556-1560 (Pubitemid 41434560)
12. Anstey KJ, von Sanden C, Salim A, et al. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007;166:367-378 (Pubitemid 47216800)
13. McGuinness B, Todd S, Passmore P, et al. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006;(2):CD004034.
14. Hernán MA, Alonso A, Logroscino G. Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology 2008;19:448-450 (Pubitemid 351543523)
15. Staessen JA, Richart T, Birkenhager WH. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 2007;49:389-400. (Pubitemid 46263218)
16. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia Aging Study. Arterioscler Thromb Vasc Biol 2000;20:2255-2260 (Pubitemid 30777782)
17. Demirovic J, Prineas R, Loewenstein D, et al. Prevalence of dementia in three ethnic groups: the South Florida Program on Aging and Health. Ann Epidemiol 2003;13:472-478 (Pubitemid 36870817)
18. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359 (Pubitemid 34251969)
19. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 1989;129:687-702.
20. Knopman DS, Ryberg S. A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Arch Neurol 1989;46:141-145 (Pubitemid 19051263)
21. Wechsler D. The Wechsler Adult Intelligence Scale - revised. New York: Psychological Corporation, 1981.
22. Lezak MD. Neuropsychological assessment. 3rd edn. New York: Oxford University Press, 1995.
23. Volcik KA, Barkley RA, Hutchinson RG, et al. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC Study participants. Am J Epidemiol 2006;164:342-348
24. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989;84:1074-1078
25. Rosengren A, Skoog I, Gustafson D, et al. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med 2005;165:321-326 (Pubitemid 40216287)
26. Akomolafe A, Beiser A, Meigs JB, et al. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol 2006;63:1551-1555 (Pubitemid 44748797)
27. Whitmer RA, Sidney S, Selby J, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005;64:277-281
28. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies. Diabetologia 2005;48:2460-2469 (Pubitemid 41738208)
29. Longstreth WT Jr, Bernick C, Manolio TA, et al. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 1998;55:1217-1225 (Pubitemid 28427493)
30. Liao D, Cooper L, Cai J, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC study. Neuroepidemiology 1997;16:149-162 (Pubitemid 27215864)
31. Sonnen JA, Larson EB, Crane PK, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007;62:406-413
32. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61:1531-1534 (Pubitemid 39350263)
33. Sonnen JA, Larson EB, Brickell K, et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol 2009;66:315-322
34. Ong KL, Cheung BMY, Wong LYF, et al. Prevalence, treatment, and control of diagnosed diabetes in the US National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol 2008;18:222-229
35. Ong KL, Cheung BMY, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69-75.
36. SHEP Cooperative Research Group. Prevention of stroke by hypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264
37. Prince MJ, Bird AS, Blizard RA, et al. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. BMJ 1996;312:801-805
38. Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-1075 (Pubitemid 36548935)
39. Lithell H, Hansson L, Skoog I, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003;21:875-886 (Pubitemid 36677151)
40. Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 2002;162:2046-2052
41. Tang M-X, Cross P, Andrews H, et al. Incidence of Alzheimer's disease in African- Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001;56:49-56.
42. Jin Y-P, Gatz M, Johansson B, et al. Sensitivity and specificity of dementia coding in two Swedish disease registries. Neurology 2004;63:739-741 (Pubitemid 39100841)
43. Phung TKT, Andersen BB, Hogh P, et al. Validity of dementia diagnoses in the Danish hospital registers. Dement Geriatr Cogn Disord 2007;24:220-228 (Pubitemid 47312673)